COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,823 Articles (22,968 medRxiv, 8,855 bioRxiv)

Most recent first Previous |  Page 1502: Articles 15011-15020  | Next

Effectiveness and Safety of Niclosamaide as Add-on Therapy to the Standard of Care Measures in COVID-19 Management: Randomized controlled clinical trial
Abdulamir, A. S., Gorial, F. I., Saaedi, S. J., Maulood, M. F., Hashim, H. A., abdulrrazaq, M. K.
10.1101/2021.06.10.21258709 — Posted: 2021-06-17
Quantitative Analysis of Genomic Sequences of Virus RNAs Using a Metric-Based Algorithm
Belinsky, A., Kouzaev, G.
10.1101/2021.06.17.448868 — Posted: 2021-06-17
Molnupiravir, an Oral Antiviral Treatment for COVID-19
Fischer, W. A., Eron, J. J., Holman, W., Cohen, M. S., Fang, L., Szewczyk, L. J., Sheahan, T. P., Baric, R. S., Mollan, K. R., Wolfe, C. R., Duke, E. R., Azizad, M. M., BorrotoiEsoda, K., Wohl, D. A., Loftis, A. J., Alabanza, P., Lipansky, F., Painter, W. P.
10.1101/2021.06.17.21258639 — Posted: 2021-06-17 Discussion: Onsite
SARS-CoV-2 spike P681R mutation enhances and accelerates viral fusion
Saito, A., Nasser, H., Uriu, K., Kosugi, Y., Irie, T., Shirakawa, K., Sadamasu, K., Kimura, I., Ito, J., Wu, J., Ozono, S., Tokunaga, K., Butlertanaka, E. P., Tanaka, Y. L., Shimizu, R., Shimizu, K., Fukuhara, T., Kawabata, R., Sakaguchi, T., Yoshida, I., Asakura, H., Nagashima, M., Yoshimura, K., Kazuma, Y., Nomura, R., Horisawa, Y., Takaori-Kondo, A., The Genotype to Phenotype Japan (G2P-Japan) Consortium, , Nakagawa, S., Ikeda, T., Sato, K.
10.1101/2021.06.17.448820 — Posted: 2021-06-17
Memory B cells control SARS-CoV-2 variants upon mRNA vaccination of naive and COVID-19 recovered individuals.
Sokal, A., Barba-Spaeth, G., Fernandez, I., Broketa, M., Azzaoui, I., de La Selle, A., Vandenberghe, A., Fourati, S., Roeser, A., Meola, A., Bouvier-Alias, M., Crickx, E., Languille, L., Michel, M., Godeau, B., Gallien, S., Melica, G., Nguyen, Y., Zarrouk, V., Canoui-Poitrine, F., Noizat-Pirenne, F., Megret, J., Pawlotsky, J.-M., Fillatreau, S., Brunhs, P., Rey, F. A., Weill, J.-C., Reynaud, C.-A., Chappert, P., Mahevas, M.
10.1101/2021.06.17.448459 — Posted: 2021-06-17
Post-Infection Entry Mechanism of Ricin A Chain-Pokeweed Antiviral Proteins (RTA-PAPs) Chimeras is Mediated by Viroporins
Hassan, Y.
10.1101/2021.06.17.448882 — Posted: 2021-06-17
Western diet increases COVID-19 disease severity in the Syrian hamster
Port, J. R., Adney, D. R., Schwarz, B., Schulz, J., Sturdevant, D. E., Smith, B. J., Avanzato, V., Holbrook, M. G., Purushotham, J., Stromberg, K. A., Leighton, I., Bosio, C., Shaia, C., Munster, V.
10.1101/2021.06.17.448814 — Posted: 2021-06-17
Specificity and Mechanism of Coronavirus, Rotavirus and Mammalian Two-Histidine-Phosphoesterases That Antagonize Antiviral Innate Immunity
Asthana, A., Gaughan, C., Weiss, S. R., Silverman, R. H.
10.1101/2021.06.16.448777 — Posted: 2021-06-17
A stem-loop RNA RIG-I agonist confers prophylactic and therapeutic protection against acute and chronic SARS-CoV-2 infection in mice
Mao, T., Israelow, B., Lucas, C., Vogels, C. B. F., Fedorova, O., Breban, M. I., Menasche, B. L., Dong, H., Linehan, M., Yale SARS-CoV-2 Genome Surveillance Initiative, , Wilen, C. B., Landry, M. L., Grubaugh, N. D., Pyle, A. M., Iwasaki, A.
10.1101/2021.06.16.448754 — Posted: 2021-06-17
Designing a Novel Multi-Epitope Vaccine against SARS-CoV-2; Implication for Viral Binds and Fusion Inhibition through Inducing Neutralizing Antibodies
Mohammadzadeh Hosseini Moghri, S. A. H., Ranjbar, M., Hassannia, H., Khakdan, F.
10.1101/2021.06.16.448772 — Posted: 2021-06-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).